Skip to Main Content

The Role of the Omentum in the Treatment of Morbid Obesity

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Information provided by (Responsible Party):

Naji Abumrad, Vanderbilt University

ClinicalTrials.gov Identifier:

NCT00212160

First received: September 13, 2005

Last updated: June 8, 2012

Last verified: June 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2013
Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)

Publications:

Fabbrini E, Tamboli RA, Magkos F, Marks-Shulman PA, Eckhauser AW, Richards WO, Klein S, Abumrad NN. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010 Aug;139(2):448-55. Epub 2010 May 7.

Hajri T, Tao H, Wattacheril J, Marks-Shulman P, Abumrad NN. Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-? and interleukin-6. Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E350-60. Epub 2010 Nov 9.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Tamboli RA, Hajri T, Jiang A, Marks-Shulman PA, Williams DB, Clements RH, Melvin W, Bowen BP, Shyr Y, Abumrad NN, Flynn CR. Reduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomy. PLoS One. 2011;6(12):e28577. Epub 2011 Dec 16.

Dunn JP, Abumrad NN, Breitman I, Marks-Shulman PA, Flynn CR, Jabbour K, Feurer ID, Tamboli RA. Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care. 2012 Jan;35(1):137-42. Epub 2011 Oct 31.